Brooks Laboratories Ltd

NSE: BROOKS · BSE: 533543 · Pharmaceuticals & Biotechnology · 19 announcements

Share price: ₹58.51
Market cap: ₹172.3 Cr
Revenue (annual): ₹85.74 Cr
Net profit (annual): ₹24.58 Cr
P/E (TTM): 13.1×Sector 47.4×
Promoter holding: 52.62%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Management Change 3 Financial Results 3 Annual General Meeting 3 Merger & Restructuring 2 Board Meeting Date 2 Debt & Borrowing 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

13 Aug 2026 19:51 IST BSE

Financial Results

Brooks Laboratories Q1 FY27 Results: Net Loss of ₹1.8 Cr

Brooks Laboratories Ltd reported revenue from operations of ₹23 Cr (-9.8% YoY) and a net loss of ₹1.8 Cr for Q1 FY27.

Key figure: Net loss ₹1.8 Cr

Open full results → Read the filing ↗

29 May 2026 20:05 IST BSE

Financial Results

Brooks Laboratories Q4 FY26 Results: Turns Profitable, Net Profit ₹1.5 Cr

Brooks Laboratories Ltd reported revenue from operations of ₹20.2 Cr (-13.3% YoY) and net profit of ₹1.5 Cr for Q4 FY26.

Key figure: Net profit ₹1.5 Cr

Open full results → Read the filing ↗

29 May 2026 20:04 IST BSE

Financial Results

Brooks Laboratories Financial Results

Brooks Laboratories reported a consolidated total income of ₹86.91 Crore for FY26. The board also appointed Mr. Prashant Rathi as CEO in addition to his CFO role.

Value: ₹86.91 Cr

Read the filing ↗